Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia

Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hereditary cancer in clinical practice 2014-04, Vol.12 (1), p.11-11, Article 11
Hauptverfasser: Hernández, Julián Esteban Londoño, Llacuachaqui, Marcia, Palacio, Gonzalo Vásquez, Figueroa, Juan David, Madrid, Jorge, Lema, Mauricio, Royer, Robert, Li, Song, Larson, Garrett, Weitzel, Jeffrey N, Narod, Steven A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue 1
container_start_page 11
container_title Hereditary cancer in clinical practice
container_volume 12
creator Hernández, Julián Esteban Londoño
Llacuachaqui, Marcia
Palacio, Gonzalo Vásquez
Figueroa, Juan David
Madrid, Jorge
Lema, Mauricio
Royer, Robert
Li, Song
Larson, Garrett
Weitzel, Jeffrey N
Narod, Steven A
description Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia. We enrolled 280 unselected women with breast cancer from a large public hospital in Medellin, Colombia. A detailed family history from each patient and a blood sample was obtained and processed for DNA analysis. Mutations in BRCA1 and BRCA2 were sought using a combination of techniques including a panel of recurrent Hispanic BRCA mutations which consists of fifty BRCA1 mutations and forty-six BRCA2 mutations, including the five recurrent Colombian BRCA mutations. All mutations were confirmed by direct sequencing. Genetic testing was successfully completed for 244 of the 280 cases (87%). Among the 244 cases, three deleterious mutations were identified (two in BRCA1 and one in BRCA2) representing 1.2% of the total. The average age of breast cancer in the mutation-positive cases was 34 years. The two BRCA1 mutations were known founder mutations (3450del4 in exon 11 and A1708E in exon 18). The BRCA2 mutation was in exon 11 (5844del5) and has not been previously reported in individuals of Colombian descent. Among the three mutation-positive families was a breast cancer family and two families with no history of breast or ovarian cancer. The frequency of BRCA mutations in unselected breast cancer cases from the Medellin region of Colombia is low and is approximately 1.2%.
doi_str_mv 10.1186/1897-4287-12-11
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3998735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3285428171</sourcerecordid><originalsourceid>FETCH-LOGICAL-b480t-b7cbc08b012151fd161379a3c40f1fd024263a9f90ba880c15f8bb829fdd8c1b3</originalsourceid><addsrcrecordid>eNp1ktFqFDEUhoNU3Hb12jsJ9KYXHZuTzGySm8J2aatQUESvQ5JJ2ikzyZrMFHwon8IXM9tdFyv1KifnfPn5-U8QegvkPYBYnIGQvKqp4BXQCuAFOtx3DkrNGVSUETpDRznfE9IwweUrNKM1ryml5BC5z8k96N4F63D0-OLLaglYh_axoniYRj12MWTcBTyF7HpnR9dik5zOI7a6vEt4XRgXxox9igMeXOv6_tfPcIpXsY-D6fRr9NLrPrs3u3OOvl1dfl19qG4-XX9cLW8qUwsyVoZbY4kwBCg04FtYAONSM1sTX66E1nTBtPSSGC0EsdB4YYyg0retsGDYHJ1vddeTKTZsMZV0r9apG3T6oaLu1NNJ6O7UbXxQTErBWVMELrYCpov_EXg6sXFQm8jVJnIFVAEUkZOdixS_Ty6PauiyLZno4OKUFTR0wRmTZT1zdPwPeh-nFEpGhQJJCJfACnW2pWyKOSfn94aAqM0_eMbCu7-D2PN_Fs9-A-66rr4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1519007913</pqid></control><display><type>article</type><title>Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia</title><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hernández, Julián Esteban Londoño ; Llacuachaqui, Marcia ; Palacio, Gonzalo Vásquez ; Figueroa, Juan David ; Madrid, Jorge ; Lema, Mauricio ; Royer, Robert ; Li, Song ; Larson, Garrett ; Weitzel, Jeffrey N ; Narod, Steven A</creator><creatorcontrib>Hernández, Julián Esteban Londoño ; Llacuachaqui, Marcia ; Palacio, Gonzalo Vásquez ; Figueroa, Juan David ; Madrid, Jorge ; Lema, Mauricio ; Royer, Robert ; Li, Song ; Larson, Garrett ; Weitzel, Jeffrey N ; Narod, Steven A</creatorcontrib><description>Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia. We enrolled 280 unselected women with breast cancer from a large public hospital in Medellin, Colombia. A detailed family history from each patient and a blood sample was obtained and processed for DNA analysis. Mutations in BRCA1 and BRCA2 were sought using a combination of techniques including a panel of recurrent Hispanic BRCA mutations which consists of fifty BRCA1 mutations and forty-six BRCA2 mutations, including the five recurrent Colombian BRCA mutations. All mutations were confirmed by direct sequencing. Genetic testing was successfully completed for 244 of the 280 cases (87%). Among the 244 cases, three deleterious mutations were identified (two in BRCA1 and one in BRCA2) representing 1.2% of the total. The average age of breast cancer in the mutation-positive cases was 34 years. The two BRCA1 mutations were known founder mutations (3450del4 in exon 11 and A1708E in exon 18). The BRCA2 mutation was in exon 11 (5844del5) and has not been previously reported in individuals of Colombian descent. Among the three mutation-positive families was a breast cancer family and two families with no history of breast or ovarian cancer. The frequency of BRCA mutations in unselected breast cancer cases from the Medellin region of Colombia is low and is approximately 1.2%.</description><identifier>ISSN: 1731-2302</identifier><identifier>ISSN: 1897-4287</identifier><identifier>EISSN: 1897-4287</identifier><identifier>DOI: 10.1186/1897-4287-12-11</identifier><identifier>PMID: 24742220</identifier><language>eng</language><publisher>Poland: BioMed Central</publisher><ispartof>Hereditary cancer in clinical practice, 2014-04, Vol.12 (1), p.11-11, Article 11</ispartof><rights>2014 Hernández et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Copyright © 2014 Hernández et al.; licensee BioMed Central Ltd. 2014 Hernández et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b480t-b7cbc08b012151fd161379a3c40f1fd024263a9f90ba880c15f8bb829fdd8c1b3</citedby><cites>FETCH-LOGICAL-b480t-b7cbc08b012151fd161379a3c40f1fd024263a9f90ba880c15f8bb829fdd8c1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998735/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998735/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24742220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández, Julián Esteban Londoño</creatorcontrib><creatorcontrib>Llacuachaqui, Marcia</creatorcontrib><creatorcontrib>Palacio, Gonzalo Vásquez</creatorcontrib><creatorcontrib>Figueroa, Juan David</creatorcontrib><creatorcontrib>Madrid, Jorge</creatorcontrib><creatorcontrib>Lema, Mauricio</creatorcontrib><creatorcontrib>Royer, Robert</creatorcontrib><creatorcontrib>Li, Song</creatorcontrib><creatorcontrib>Larson, Garrett</creatorcontrib><creatorcontrib>Weitzel, Jeffrey N</creatorcontrib><creatorcontrib>Narod, Steven A</creatorcontrib><title>Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia</title><title>Hereditary cancer in clinical practice</title><addtitle>Hered Cancer Clin Pract</addtitle><description>Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia. We enrolled 280 unselected women with breast cancer from a large public hospital in Medellin, Colombia. A detailed family history from each patient and a blood sample was obtained and processed for DNA analysis. Mutations in BRCA1 and BRCA2 were sought using a combination of techniques including a panel of recurrent Hispanic BRCA mutations which consists of fifty BRCA1 mutations and forty-six BRCA2 mutations, including the five recurrent Colombian BRCA mutations. All mutations were confirmed by direct sequencing. Genetic testing was successfully completed for 244 of the 280 cases (87%). Among the 244 cases, three deleterious mutations were identified (two in BRCA1 and one in BRCA2) representing 1.2% of the total. The average age of breast cancer in the mutation-positive cases was 34 years. The two BRCA1 mutations were known founder mutations (3450del4 in exon 11 and A1708E in exon 18). The BRCA2 mutation was in exon 11 (5844del5) and has not been previously reported in individuals of Colombian descent. Among the three mutation-positive families was a breast cancer family and two families with no history of breast or ovarian cancer. The frequency of BRCA mutations in unselected breast cancer cases from the Medellin region of Colombia is low and is approximately 1.2%.</description><issn>1731-2302</issn><issn>1897-4287</issn><issn>1897-4287</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1ktFqFDEUhoNU3Hb12jsJ9KYXHZuTzGySm8J2aatQUESvQ5JJ2ikzyZrMFHwon8IXM9tdFyv1KifnfPn5-U8QegvkPYBYnIGQvKqp4BXQCuAFOtx3DkrNGVSUETpDRznfE9IwweUrNKM1ryml5BC5z8k96N4F63D0-OLLaglYh_axoniYRj12MWTcBTyF7HpnR9dik5zOI7a6vEt4XRgXxox9igMeXOv6_tfPcIpXsY-D6fRr9NLrPrs3u3OOvl1dfl19qG4-XX9cLW8qUwsyVoZbY4kwBCg04FtYAONSM1sTX66E1nTBtPSSGC0EsdB4YYyg0retsGDYHJ1vddeTKTZsMZV0r9apG3T6oaLu1NNJ6O7UbXxQTErBWVMELrYCpov_EXg6sXFQm8jVJnIFVAEUkZOdixS_Ty6PauiyLZno4OKUFTR0wRmTZT1zdPwPeh-nFEpGhQJJCJfACnW2pWyKOSfn94aAqM0_eMbCu7-D2PN_Fs9-A-66rr4</recordid><startdate>20140417</startdate><enddate>20140417</enddate><creator>Hernández, Julián Esteban Londoño</creator><creator>Llacuachaqui, Marcia</creator><creator>Palacio, Gonzalo Vásquez</creator><creator>Figueroa, Juan David</creator><creator>Madrid, Jorge</creator><creator>Lema, Mauricio</creator><creator>Royer, Robert</creator><creator>Li, Song</creator><creator>Larson, Garrett</creator><creator>Weitzel, Jeffrey N</creator><creator>Narod, Steven A</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140417</creationdate><title>Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia</title><author>Hernández, Julián Esteban Londoño ; Llacuachaqui, Marcia ; Palacio, Gonzalo Vásquez ; Figueroa, Juan David ; Madrid, Jorge ; Lema, Mauricio ; Royer, Robert ; Li, Song ; Larson, Garrett ; Weitzel, Jeffrey N ; Narod, Steven A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b480t-b7cbc08b012151fd161379a3c40f1fd024263a9f90ba880c15f8bb829fdd8c1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández, Julián Esteban Londoño</creatorcontrib><creatorcontrib>Llacuachaqui, Marcia</creatorcontrib><creatorcontrib>Palacio, Gonzalo Vásquez</creatorcontrib><creatorcontrib>Figueroa, Juan David</creatorcontrib><creatorcontrib>Madrid, Jorge</creatorcontrib><creatorcontrib>Lema, Mauricio</creatorcontrib><creatorcontrib>Royer, Robert</creatorcontrib><creatorcontrib>Li, Song</creatorcontrib><creatorcontrib>Larson, Garrett</creatorcontrib><creatorcontrib>Weitzel, Jeffrey N</creatorcontrib><creatorcontrib>Narod, Steven A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hereditary cancer in clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández, Julián Esteban Londoño</au><au>Llacuachaqui, Marcia</au><au>Palacio, Gonzalo Vásquez</au><au>Figueroa, Juan David</au><au>Madrid, Jorge</au><au>Lema, Mauricio</au><au>Royer, Robert</au><au>Li, Song</au><au>Larson, Garrett</au><au>Weitzel, Jeffrey N</au><au>Narod, Steven A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia</atitle><jtitle>Hereditary cancer in clinical practice</jtitle><addtitle>Hered Cancer Clin Pract</addtitle><date>2014-04-17</date><risdate>2014</risdate><volume>12</volume><issue>1</issue><spage>11</spage><epage>11</epage><pages>11-11</pages><artnum>11</artnum><issn>1731-2302</issn><issn>1897-4287</issn><eissn>1897-4287</eissn><abstract>Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia. We enrolled 280 unselected women with breast cancer from a large public hospital in Medellin, Colombia. A detailed family history from each patient and a blood sample was obtained and processed for DNA analysis. Mutations in BRCA1 and BRCA2 were sought using a combination of techniques including a panel of recurrent Hispanic BRCA mutations which consists of fifty BRCA1 mutations and forty-six BRCA2 mutations, including the five recurrent Colombian BRCA mutations. All mutations were confirmed by direct sequencing. Genetic testing was successfully completed for 244 of the 280 cases (87%). Among the 244 cases, three deleterious mutations were identified (two in BRCA1 and one in BRCA2) representing 1.2% of the total. The average age of breast cancer in the mutation-positive cases was 34 years. The two BRCA1 mutations were known founder mutations (3450del4 in exon 11 and A1708E in exon 18). The BRCA2 mutation was in exon 11 (5844del5) and has not been previously reported in individuals of Colombian descent. Among the three mutation-positive families was a breast cancer family and two families with no history of breast or ovarian cancer. The frequency of BRCA mutations in unselected breast cancer cases from the Medellin region of Colombia is low and is approximately 1.2%.</abstract><cop>Poland</cop><pub>BioMed Central</pub><pmid>24742220</pmid><doi>10.1186/1897-4287-12-11</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1731-2302
ispartof Hereditary cancer in clinical practice, 2014-04, Vol.12 (1), p.11-11, Article 11
issn 1731-2302
1897-4287
1897-4287
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3998735
source DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
title Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A41%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20BRCA1%20and%20BRCA2%20mutations%20in%20unselected%20breast%20cancer%20patients%20from%20medell%C3%ADn,%20Colombia&rft.jtitle=Hereditary%20cancer%20in%20clinical%20practice&rft.au=Hern%C3%A1ndez,%20Juli%C3%A1n%20Esteban%20Londo%C3%B1o&rft.date=2014-04-17&rft.volume=12&rft.issue=1&rft.spage=11&rft.epage=11&rft.pages=11-11&rft.artnum=11&rft.issn=1731-2302&rft.eissn=1897-4287&rft_id=info:doi/10.1186/1897-4287-12-11&rft_dat=%3Cproquest_pubme%3E3285428171%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1519007913&rft_id=info:pmid/24742220&rfr_iscdi=true